Drugs / MTX
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04841434 | Jun 2021 → Dec 2024 | central nervous system non-hodgkin lymphoma | Charite University, Berlin, Germany | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | “MTX is given at a dose according to the allocated dose level cohort as a 4-hour IV infusion.” NCT04841434 ↗ |